INTRODUCTION:
As many as 5% of all couples trying to conceive have two
consecutive miscarriages and 1% have three or more consecutive
losses. Uncertainties regarding the cause and controversies
surrounding management of recurrent pregnancy loss are two
reasons that recurrent pregnancy loss remains particularly
frustrating problem for physicians and patients. Although
recurrent pregnancy loss has been well published in the news
media and women’s magazines, some articles are misleading and
encourage couples to seek unproved diagnostic tests and
controversial treatments. Recommendations in the medical
literature are also conflicting and have done little to clarify
the situations. We shall consider various causes associated RSA
in depth.
MORPHOLOGIC AND GENETIC ABNORMALITIES: -
Because most embryos from first trimester spontaneous
abortions are chromosomal or morphologically abnormal treatable
maternal or paternal factors are not involved in most cases.
CHROMOSOMAL ANOMALIES AND R.S.A.: -
Structural Chromosomal Anomalies & Recurrent Pregnancy Loss:
· Seen in 3% of cytogenetically abnormal conceptus.
· Commonest type-Robertsonian translocations.
· Other types: Inversions, Ring Chromosomes
· Structural translocations: relatively more common in RSA.
· Higher in couples with H/o both RSA and anomalies or SB
infants.
· Carriers of ( Pericentric inversion ) : high risk ( abnormal
offspring)
· A large chromosomal segment involves early embryonic
lethality.
Reproductive Risk In Structural
Abnormalities:-
· Risks studied from Robertsonian translocation between
chromosomes 14 & 21. (N) gametes of other partner)
When
chromosomal anomalies are found
Most common
anomalies are autosomal trisomies. Trisomies 13,16,18,21,22 and X are most
commonly found. Others probably do not allow embryonic
development. Their contribution to pre-implantation loss is
uncertain. Numerical abnormalities are result of non-disjunction
and uneven distribution of chromosomes at cell division. Most
abnormalities arise from errors in meiosis and advancing
maternal age is associated with an increased risk of autosomal
trisomy.
Recurrent Aneuploidy: Role In RPL
-
Chromosomal anomalies of the embryos are the most common
cause of early pregnancy loss
-
50% of early
spontaneous abortions are cytogenetically abnormal as
against 5% in still births and 0.5% in live births. Most
chromosomal abnormalities result in disordered development
incompatibility a prolonged intra uterine survival and live
birth.
-
The most common
type of parental chromosomal abnormality is a balanced
translocation C a reported prevalence of 2.5% in couples
within unselected population.
-
An increased
number of chromosomes breaks and eccentric fragments
pericentric inversions in seen in recurrent abortions group.
This presumably would lead to broth, the loss of motility
unstable elements during cell divisions and an increased
rate of aneuploidy contributing to early embryonic loss.
-
Increased number of chromosome breaks and eccentric
fragments seen in RSA group.
-
Some chromosome
bear heteromorphisms such as large heterochromatic
centromeres, pericentric inversions, large or double
satellites and fragments have been implicated in mitotic
instability and a tendency towards increase risk for
aneuploidy.
Embryonic aneuploidy is responsible for
sporadic and recurrent miscarriages, and a molecular study
indicates that the mechanism of aneuploidy is more complicated
than previously appreciated. Preliminary studies using DNA
analytic techniques suggest that the total genetic contribution
to pregnancy loss has been unclear estimated. For example,
abnormalities in the aborted embryo due to single gene mutation
or mutations at several loci are not detected by the usual
karyotype are probably important in detecting C chromosomal and
gene abnormality are clinically significant. Immunogentic
factors at the maternal fetal interface are also the subject of
intense investigations. These new development and other various
scenarios strengthen the suspicion that eventually early
pregnancy loss may be determined to be largely genetic.
MANAGEMENT: -
Relevant Genetic Counseling: -
-
Karyotyping of couples will
reveal that 3.8% have some abnormality, most frequently a
balanced chromosomal rearrangement or a translocation.
-
It is important to emphasize
that karyotyping uncovers only a percentage of those
pregnancies lost due to genetic abnormalities ( e.g. single
gene defect are missed)
-
If the karyotype is abnormal,
nothing can be clove to lesson the chances for another
abortion, however C more abnormalities there is a 50% chance
that the next pregnancy will be normal.
-
Amniocentesis on CV biopsy
should be encouraged in any pregnancy in couples C a
previous abnormal karyotype because of the risk of an
abnormal child.
-
If aneuploidy is documented on
a previous abortion a centrally timed insemination is
advocated based on animal studies relating aneuploidy to
again of ovum of sperm. The other choice is of donor
insemination.
-
If euploidy has been documented
on a previous abortion anatomic or endocrine factors should
be corrected.
-
Point genetic mutations could
be responsible for abortion by causing a gene to become
lethal.
-
Empirically, the birth of a
trisomic infant places a woman at an
-
approximately 1% increased risk
for a subsequent trisomic conceptus. There is a small but
statistically insignificant increased risk for women who
have had a trisomic abortus to have a subsequent trisomic
abortion.
-
There
is a stronger tendency for ensuring abortion to be
cytogenetically normal when index abortion has a normal
karyotype. If atleast some of the antecedent abortions are
trisomic, There probably is an increased risk for
recurrence.
ANATOMIC DEFECTS: -
The two most common congenital malformations of the uterus
associated with a recurrent pregnancy loss are Subseptate and
bicornuate anomalies. Hysterosalpingography is still the best
and most practical way to detect these anomalies, but
Laparoscopy and hysteroscopy are needed to distinguish the
septate from the bicornuate uterus is simplified by
hysteroscopic resection of the septum, but an abdominal
metroplasty may be required for the bicornuate uterus. After
either technique, the pregnancy success rate is about 70% to 90%
and most physicians are convinced of this value. However, no
randomized trial has ever been done, and some any patients with
these anomalies have successful pregnancies. Each patient should
be evaluated carefully and the selection for surgical correction
must be individualized, because surgical treatment not always
necessary.
UTERINE ANOMALIES AND RECURRENT
MISCARRIAGES: -
·
Prevalence of uterine anomalies
in women with recurrent miscarriage is about 10%
·
Prevalence in general
population is unknown.
Considering the anomalies one by one: -
UNICORNUATE UTERUS: -
- Rare anomaly
- Fetal pregnancy lost within the first 2 trimester. Prematurity
–20%.
UTERUS DIDELPHYS: -
· Fetal Survival rate 64% (without surgical correction)
· Best prognosis
· Surgical procedures to treat pregnancy losses-rarely indicated
· Benefit of metroplasty-not certain
BICORNUATE UTERUS: -
- 14% of women with poor reproductive
performance can have this.
- 28% abortion rate
- 20% prematurity rate in partial bicornuate uterus
- 66% prematurity rate in complete bicornuate uterus
- Cervical incompetence incidence is increased. timely cervical
encerclage recommended.
SEPTATE UTERUS: -
· Reports of 28% to 75% live birth rates in different studies.
· Diagnosis: H.S.G., USG., laparoscopy
· Abdominal metroplasty or hysteroscopic guided septum
transection: Advantages-simple procedure and avoids pelvic
adhesions, reduced post of morbidity. No requirement for
caesarian section
ACQUIRED UTERINE DEFFECTS: -
Ashermann’s Syndrome:
-Pregnancy resulting in abortion- 40%
-Diagnosis : -USG-HSG-HYSTEROSCOPY
-Hysteroscopic surgery
Value of Treatment in recurrent
pregnancy loss:
The optimal treatment for uterine anomalies is still a matter
of debate. Open surgical correction of congenital anomalies has
been reported to give successful subsequent pregnancy outcome
but may be associated significant postoperative infertility of
pelvic adhesions.
Majority of studies of RPL on uterine anomalies are without
control, comparing miscarriage rate before and after treatment
in the same woman. Interpretation of such results can be flawed.
Hysteroscopic techniques are attractive, but results from
randomized control studies are lacking. Cervical
incompetence is probably over diagnosed.
Uterine anomaly
|
Pregnancy |
Surgery |
Post-Op. Reprod. Perf. |
Unicornuate uterus |
40% fetal Survival
|
Prophylactic cervical
cerclage
|
not well studied |
Uterus Didelphys
|
64% fetal survival |
Metroplasty |
50-75%live birth rate |
Bicornuate uterus |
55% fetal survival |
surgical unification
of 2 endometrial cavities.
With/ Without cerclage |
85% viable infants |
Septate uterus
|
28% live birth rate |
Abdominal metroplasty or
hysteroscopic septum
transection |
70% survival rate
87% survival rate |
Asherman Syndrome |
30% fetal survival |
Hysteroscopic adhesions |
87% fetal survival |
ENDOCRINE: -
Endocrine modulation of decidual
immunity
· Female sex steroid hormones stimulate production of
many cytokines by endometrial stromal and epithelial
cells and the blastocyst.
· Cytokines are endocrine and paracrine biologic second
messengers.
·Leukocytes influx maturation.
· The most popular therapy is progesterone
supplementation.
·Other treatment include HCG administration
·Reviewers have concluded that benefit of treatment of
LPD is not known
|
The role of endocrine factors as a cause of
recurrent spontaneous abortion is controversial. Diabetes
mellitus and thyroid diseases do not represent pregnancy loss.
Luteal-phase defect has been questioned because there are no
accurate methods for diagnosis and no convincing evidence of
correction with treatment exists.
The corpus luteum is an unusual endocrine gland, highly diverse
in function and important for successful reproduction in all
mammalian species. Much controversy exists about the luteal
function in human and hour defects in luteal function affects
reproduction. Disagreement has been due to lack of accurate
diagnosis and controlled studies to determine whether correction
of the luteal phase defect is worthwhile when treating female
reproductive problems. The donor egg recipient model from
assisted reproductive technology programs has shown that corpus
luteum. The mechanism by which these steroids stimulate a uterus
to be receptive to implantation of the embryo is not known.
Several proteins produced by the endometrium are the markers for
uterine receptivity. Furthers work needs to be done to correlate
these markers C sub sequent pregnancy outcome. A noninvasive
marker for uterine receptivity is ultrasonographic evaluation of
the endometrium. But the sensitivity is low (only 20% - 60%).
AUTOMMUNE DISORDERS :-
The failure of self tolerance or evoking of a humoral or
cellular immune response directed against self-antigens is known
as autoimmunity.
· It has been known service decades that a systemic autoimmune
condition such as SLE is associated with a risk of pregnancy
loss.
· Antiphospholipid antibodies comprise a family of
autoantibodies that have a well-established association with
fetal loss, which share in common reactivity with negatively
charged phospholipids.
ANTIPHOSPHOLIPID ANTIBODY SYNDROME: -
What constitutes APA Syndrome?:
(Must include one clinical of one serological
feature)
Clinical Features
Recurrent venous or arterial thrombosis
Recurrent fetal loss
Thrombocytopenia
Serological features: -
Ig G > 20 GPL
Ig M >10 MPL |
These are essentially missed
abortions. Treatment protocols are many. All give good results.
But the main stay is Aspirin, Corticosteroids and Heparin. We
got working in this field about 15 years ago. Initially we
investigated only recurrent missed abortions of late I-trimester
and II trimester. Nearly 80% of such carefully selected cases
tested positive. We then enlarged the scope of these
investigations to other areas as well. We found association of
APA syndrome with other obstetric condition notable amongst
these was pre-eclampsia remote from term. Treatment protocol
established in these cases was according to the degree of
positivity. We classified <10 GPL as negative, 10-20 as
weakly positive, 20 to 100 as moderately positive
and more than 100 as strongly positive. For weak and
moderate positive cases, we gave low dose aspirin 1.2 mg/kg./day
in the interval period. Than allowed a conception. We restarted
aspirin at 12 weeks and went on to give for 36 weeks. In strong
positive cases we gave prednisolone in a dose of 10-20 mg/day
for three months in the interval period allowed a conception and
then started aspirin in the some dose from 12 weeks to 36 wks.
Our published data showed very satisfactory results in the
otherwise furious looking conditions.
ANTINUCLEAR ANTIBODIES:-
·Modest elevations are common, nonspecific and usually of no
clinical significance.
·Presently ANA determination is not recommended as part of
evaluation for RSA.
ANTITHYROID ANTIBODIES :-
OR
LUPUS ANTICOAGULANT:-
Mechanism of action: -
· 1) Platelet activation with a lower threshold for aggression
induced by interference with phospholipids part of prothrombin
activation complex.
· 2) Inhibition of prostacycline formation in vessel walls by
inhibiting release of arachidonic acid from membrane
phospholipids.
· 3) Pre-kallikrein inhibition
· 4) Prevention of physiological charges in the spiral arteries
which results in decreased blood supply to the decide
culminating the fetal hypoxia.
· 5) Impaired fibrinolytic system.
ENVIRONMENTAL FACTORS:-
Environmental causes from both the medical and psychological
perspectives.
We are less certain about the contribution of environmental,
physical, and chemical agents to the incidence of spontaneous
abortion. Although we realize that spontaneous abortions are a
significant medical and emotional burden to a family a surviving
malformed infant can be greater burden to that family.
We do not have an accurate picture of the contribution of
environmental agents to the incidence of spontaneous abortion.
At the present time it would appear that only a very small
proportion of abortions could be attributed toxicants during
pregnancy. Conversely, it is the scientific and medical
community’s responsibility to prevent the introduction and use
of agents that cause unwanted embryonic and fetal loss. Because
the teratogenic and abortgenic effects of environmental agents
differ, one can not conclude that an agent is an abortifacient
because it is not teratogenic.
INFECTION: -
The best evidence suggests that infection is an occasional cause
of sporadic spontaneous abortion, and consistent with
statistical probability, recurrent miscarriage due to infection
occurs with a frequency that is much lower. In the medical
literature, the limited evidence linking infection and
recurrent pregnancy loss in humans remains largely anecdotal and
generally cannot be reproduced in prospective studies.
Probable factors that play a role
in the risk of abortion due to infection are the
following: -
1) Primary exposure during gestation
2) The capability of the organism to cause placental
infection.
3) The development of an infection carrier state.
4) Immune-compromised caused by immune suppressant
chemotherapy corticosteroids or acquired immune
deficiency syndrome.
|
Exposure to a microbe that can establish
chronic infection that can spread to the placenta in an immuno-compromised
patient is probably the most obvious risk situation for habitual
abortion. In routine medical practice, it is not necessary or
efficient to screen universally for the unexpected but pt is
necessary to be aware of the rare possibilities.
PSYCHOLOGICAL FACTORS: -
Unfortunately there has been little formalized research with
respect to the psychological causes and reactions to multiple
pregnancy loss. Although at one time it was thought that
substantial psychopathologic disorders accounted for many early
pregnancy losses, little data support this concept. Although
emotional responses to miscarriages have been documented for
persons experiencing a single miscarriage., little information
is available about the premorbid personality or psychological
reactions of couples who experience repeated pregnancy loss.
Much of what we know is not based on quantitative prospective
studies but is theretic and based on anecdotal observations.
Finally there is also an absence of prospective, well-designed
studies that evaluate the value of the sorts of therapies that
are commonly used to manage the psychological consequences of
repeated pregnancy loss. None the less several principles exist
that patients and this their therapists have found useful. Soon
we hope to see more interest in prospective, randomized trial of
various therapeutic options for these couples.
CONCLUSIONS: -
A sympathetic attitude is essential in
caring for patients with pregnancy loss. Trust and support is
best established by tactful and though discussions between the
physician and the couple. The table before summarizes
recommendations for an efficient and cost effective diagnostic
work-up in patients with recurrent miscarriage. Treatment of
maternal non-immunology factors cases. When the clinical and
laboratory evaluation is negative, approximately 60% of those
couples will achieve a successful pregnancy with no treatment.
Therefore further attempts at pregnancy without treatment is
often justified depending upon the age and wishes of the couple.
Lack age immunizations seems best reserved for carefully
selected patients who have no other options and who understand
the risks, cost, and pregnancy success rates with and without
treatment.

|